CRISPR Therapeutics Receives FARA Grant to Develop Gene Editing Therapies for Friedreich’s Ataxia – Friedreich’s Ataxia News
Friedreich’s Ataxia News |
CRISPR Therapeutics Receives FARA Grant to Develop Gene Editing Therapies for Friedreich's Ataxia
Friedreich’s Ataxia News “We believe that the combination of CRISPR's pioneering gene-editing capabilities with Dr. Marek Napierala's deep expertise in FA may accelerate the development of new therapies for FA,” Jennifer Farmer, FARA's executive director, said in a press release. |
